eXmoor Pharma

We recognise the significant impact the biopharma industry has on the environment. At eXmoor, our Green Team is dedicated to prioritising sustainability across all aspects of our business operations.   Our Achievements So Far: Facility Build: Of the 3000 tonnes of demolition materials generated during site preparation, 98% was recycled and reused for the construction of our Cell and Gene Therapy Centre, which also features substantial solar panelling, 10 electric vehicle charging points, and fossil fuel free heating and cooling provided by heat pumps and recovered from exhaust air. Lab Initiatives: We've participated in a pilot scheme to make our labs more sustainable, increased the percentage of waste diverted to recycling streams and introduced a traffic light system to reduce energy consumption in our lab spaces. Raising Awareness: We have organised a variety of activities to promote environmental awareness, including local park clean-ups, cycle-to-work days, plant swaps, and nature photography competitions.   We are excited to showcase our future initiatives, including recognised environmental accreditations, more sustainable alternatives for lab equipment and consumables, and much more. Stay tuned for these implementations!   Talk to our team to find out more! 🌿 #Greenteam #Sustainability #Environmentallyaware

Matthew Paterson shares his insights on investment trends in the CGT sector ... "Investors are being more cautious about which assets to invest in, companies are being more selective on which assets to progress into development, and cost optimization has become a higher priority for many companies." eXmoor can make your investment go further by first identifying the optimum cost drivers for development and then offering robust, scale-down models for maximum cost efficiency. Speak to our team to find out how we can maximise the impact of your investment. #celltherapy #genetherapy #costofgoods #processdevelopment

eXmoor's CCO Matthew Paterson recently spoke with Drug Discovery World to share his highlights from #BIO and #ASGCT. Read the article here 👇 https://lnkd.in/eSbjeHcy

Did you miss European Pharmaceutical Review "The Future of Bio/Pharmaceutical Analysis Online Summit 2024"? Well, it's all available on-demand and is free to access (but does need registration)! Robert Scott, QP and Senior GMP Compliance Consultant at eXmoor shares his opinion and advice for CGT developers in the panel session "CMC considerations for cell and gene therapies" https://lnkd.in/eUx7entr 

We're excited to be joining the other 198 companies attending #WIATGlobal tomorrow! Laura Murray, Kate Fynes and Clare Blue will be happy to meet virtually throughout the day. Looking forward to it! #WomeninSTEM #CellandGeneTherapy

Kate Fynes, CMC Translation Consultant at eXmoor Pharma and co-founder of The CGT Circle will be joining Lindsey Clarke and Nicola Ambler for a virtual panel discussion at Phacilitate Women in Advanced Therapies Global!   They'll be taking stock of the insights gained and lessons learned over the past year from The CGT Circle and its many local, community-led events. Wednesday, July 10, 2024 4:30 PM to 5:15 PM · 45 min (Europe/London)   Register for the free WIAT Global event here 👉 Women in Advanced Therapies Global - https://bit.ly/45RSjSV   #womeninadvancedtherapies #womeninscience #cgtcircle #WIATglob

Happy Pride Month! 🎉 eXmoor Pharma is dedicated to supporting the LGBTQ community and celebrates a diverse and inclusive workplace. We strive in creating a work environment where everyone feels respected, valued and accepted.   This week we created our own rainbow (of sorts) in the office with colleagues wearing pride colours! 🌈 #LGBTQ #PrideMonth #Diversity #Equality

Daphné Bocciarelli (Head of Viral Vector) and Ruxandra-Maria Comisel (Consultant Analyst) will be attending the BioIndustry Association (BIA) #WomeninBiotech event tomorrow, hosted by the University of Bristol and supported by CMS. We are looking forward to a thought-provoking session about female entrepreneurship in deep biotech and connecting with the Bristol community. See you there! https://lnkd.in/gEUtJtq6

Take a look at the services we provide to streamline and successfully deliver a build, retrofit or renovation of a facility dedicated to cell or gene therapy manufacturing. 👇 #GMPfacility #GMPcompliance #Celltherapy #Genetherapy

eXmoor’s QP and GMP Compliance consultant, Robert Scott will be part of a panel discussing the latest recommendations for chemistry and manufacturing controls required to identify the potency, purity and safety of advanced therapeutic medicinal products (ATMPs).   Joined by expert speakers -   Adriano Leuzzi - REITHERA Dolly (Doli) P. - Major Advanced Therapy Developer Dan Pearce - Adaptimmune Scott Burger - Advanced Cell & Gene Therapy, LLC   Register now for The Future of Bio/Pharmaceutical Analysis Online Summit 2024 presented by the European Pharmaceutical Review! 👇 📅: 20 June 2024 ⌚: Session 4 - 12.30 – 2.00 pm CET https://lnkd.in/e42KMkEU